Skip to main content
Top
Published in: Acta Diabetologica 3/2010

01-09-2010 | Original Article

Independent factors associated with depression in type 1 diabetes mellitus

Authors: Lucas Francisco Manarte, S. Dias, C. Góis, J. M. Boavida

Published in: Acta Diabetologica | Issue 3/2010

Login to get access

Abstract

Diabetes has been associated with depression since Thomas Willis’ work in 1684 (Rubin and Peyrot in Diabetes Metab Rev 18:173–175, 2002). The aim of this study is to identify social and clinical factors independently associated with depression in individuals with type 1 diabetes. We carried out a descriptive transversal study with 110 type 1 diabetes patients, administered a questionnaire and obtained demographical and diabetes-related data (number of years from diagnosis, initial admission at diagnosis, glycated hemoglobin, number of complications, insulin dose, number of insulin injections per day, admission for ketoacidosis or hypoglycemia at diagnosis, and specific diabetes complications such as nephropathy, retinopathy, peripheral neuropathy, coronariopathy, and amputation). Depressive symptoms were quantified using the Hamilton Score. We used T tests to investigate potential relations between the covariates and depression (Hamilton score). We concluded the following: as few as 10% of our patients had glycated hemoglobin under 7%; women had more symptoms of depression, and there are four independent factors associated with depression in individuals with type 1 diabetes mellitus: age, Graffar score, admission for ketoacidosis, and insulin dose.
Literature
1.
go back to reference Rubin RR, Peyrot M (2002) Was Willis right? Thoughts on the interaction of depression and diabetes. Diabetes Metab Rev 18:173–175CrossRef Rubin RR, Peyrot M (2002) Was Willis right? Thoughts on the interaction of depression and diabetes. Diabetes Metab Rev 18:173–175CrossRef
2.
go back to reference Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge Murray CJL, Lopez AD (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard University Press, Cambridge
3.
go back to reference Egede LE, Zheng D (2003) Independent factors associated with major depressive disorder in national sample of individuals with diabetes. Diabetes Care 26:104–111CrossRefPubMed Egede LE, Zheng D (2003) Independent factors associated with major depressive disorder in national sample of individuals with diabetes. Diabetes Care 26:104–111CrossRefPubMed
4.
go back to reference Lustman PJ, Freedland KE, Carney RM, Hong BA, Clouse RE (1992) Similarity of depression in diabetic and psychiatric patients. Psychosom Med 54(5):602–611PubMed Lustman PJ, Freedland KE, Carney RM, Hong BA, Clouse RE (1992) Similarity of depression in diabetic and psychiatric patients. Psychosom Med 54(5):602–611PubMed
5.
go back to reference Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(7):934–942CrossRefPubMed Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(7):934–942CrossRefPubMed
6.
go back to reference de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63(4):619–630PubMed de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63(4):619–630PubMed
7.
go back to reference Lustman PJ, Clouse RE, Ciechanowski PS, Hirsch IB, Freedland KE (2005) Depression-related hyperglycemia in type 1 diabetes: a mediational approach. Psychosom Med 67(2):195–199CrossRefPubMed Lustman PJ, Clouse RE, Ciechanowski PS, Hirsch IB, Freedland KE (2005) Depression-related hyperglycemia in type 1 diabetes: a mediational approach. Psychosom Med 67(2):195–199CrossRefPubMed
8.
go back to reference Blumenthal JA, Williams RS, Wallace A, Williams RB Jr, Needles TL (1982) Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 44:519–527PubMed Blumenthal JA, Williams RS, Wallace A, Williams RB Jr, Needles TL (1982) Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 44:519–527PubMed
9.
go back to reference Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL (1990) Depression and the dynamics of smoking. JAMA 264:1541–1545CrossRefPubMed Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL (1990) Depression and the dynamics of smoking. JAMA 264:1541–1545CrossRefPubMed
10.
go back to reference Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS (1995) Major depression and medication adherence in coronary artery disease. Health Psychol 14:88–90CrossRefPubMed Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS (1995) Major depression and medication adherence in coronary artery disease. Health Psychol 14:88–90CrossRefPubMed
11.
12.
13.
go back to reference Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New York Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New York
14.
go back to reference Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence o comorbid depression in adults with diabetes: a meta-analyses. Diabetes Care 24:1069–1078CrossRefPubMed Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence o comorbid depression in adults with diabetes: a meta-analyses. Diabetes Care 24:1069–1078CrossRefPubMed
15.
go back to reference Katon W, Von Korff M, Ciechanowski P, Russo J et al (2004) Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920CrossRefPubMed Katon W, Von Korff M, Ciechanowski P, Russo J et al (2004) Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27:914–920CrossRefPubMed
16.
go back to reference Egede LE (2004) Diabetes, major depression and functional disability among U.S. adults. Diabetes Care 27:421–428CrossRefPubMed Egede LE (2004) Diabetes, major depression and functional disability among U.S. adults. Diabetes Care 27:421–428CrossRefPubMed
17.
go back to reference Kovacs M, Mukerji P, Drash A, Iyengar S (1995) Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 18(12):1592–1599CrossRefPubMed Kovacs M, Mukerji P, Drash A, Iyengar S (1995) Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 18(12):1592–1599CrossRefPubMed
18.
go back to reference Peyrot M, Rubin RR (1997) Levels and risks for depression and anxiety symptomatology among diabetic adults. Diabetes Care 20:585–590CrossRefPubMed Peyrot M, Rubin RR (1997) Levels and risks for depression and anxiety symptomatology among diabetic adults. Diabetes Care 20:585–590CrossRefPubMed
19.
go back to reference Chapman DP, Geraldine PS, Strine TW (2005) The vital link between chronic disease and depressive disorders. Prev Chronic Dis 02:01–10 Chapman DP, Geraldine PS, Strine TW (2005) The vital link between chronic disease and depressive disorders. Prev Chronic Dis 02:01–10
20.
go back to reference Black S, Markides K, Ray L (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican with type 2 diabetes. Diabetes Care 26:2822–2828CrossRefPubMed Black S, Markides K, Ray L (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican with type 2 diabetes. Diabetes Care 26:2822–2828CrossRefPubMed
22.
23.
go back to reference Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP (1992) Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemioloical Follow-up Study. Am J Epidemiol 158:416–423CrossRef Carnethon MR, Kinder LS, Fair JM, Stafford RS, Fortmann SP (1992) Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemioloical Follow-up Study. Am J Epidemiol 158:416–423CrossRef
24.
go back to reference Lustman PS, Clouse RE, Carney RM (1988) Depression and the reporting of diabetes symptoms. Int J Psychiatr Med 18:303–325 Lustman PS, Clouse RE, Carney RM (1988) Depression and the reporting of diabetes symptoms. Int J Psychiatr Med 18:303–325
25.
go back to reference De Groot M, Jacobson AM, Samson JA, Welch G (1999) Glycemic control and major depression in patients with type 1 and 2 diabetes mellitus. J Psychosom Res 46(5):425–435CrossRefPubMed De Groot M, Jacobson AM, Samson JA, Welch G (1999) Glycemic control and major depression in patients with type 1 and 2 diabetes mellitus. J Psychosom Res 46(5):425–435CrossRefPubMed
26.
go back to reference Miranda AL, Tilburg V, McCaskill CC, Lane JD et al (2001) Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 63:551–555 Miranda AL, Tilburg V, McCaskill CC, Lane JD et al (2001) Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 63:551–555
27.
go back to reference Paile-Hyvarinen M, Wahlbeck K, Eriksso JG (2003) Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single blind randomised placebo controlled trial. BMC Fam Pract. doi:10.1186/1471-2296-4-7 Paile-Hyvarinen M, Wahlbeck K, Eriksso JG (2003) Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single blind randomised placebo controlled trial. BMC Fam Pract. doi:10.​1186/​1471-2296-4-7
28.
go back to reference Amsterdam JD, Shults J, Rutherford N, Schwartz S (2006) Safety and efficacy of s-citalopram in patients with co-mordib major depression and diabetes mellitus. Neuropsychobiology 54:208–214CrossRefPubMed Amsterdam JD, Shults J, Rutherford N, Schwartz S (2006) Safety and efficacy of s-citalopram in patients with co-mordib major depression and diabetes mellitus. Neuropsychobiology 54:208–214CrossRefPubMed
29.
go back to reference Lustman PJ, Clouse RE, Nix BD, Freedland KE et al (2006) Sertraline for prevention of depression recurrence in diabetes mellitus. Arch Gen Psychiatr 63:521–529CrossRefPubMed Lustman PJ, Clouse RE, Nix BD, Freedland KE et al (2006) Sertraline for prevention of depression recurrence in diabetes mellitus. Arch Gen Psychiatr 63:521–529CrossRefPubMed
30.
go back to reference Miller GE, Freedland KE, Carbey RM, Stetler CA, Banks WA (2003) Pathways linking depression, adiposity and inflammatory markers in young adults. Brain Behav Immun 17:276–285CrossRefPubMed Miller GE, Freedland KE, Carbey RM, Stetler CA, Banks WA (2003) Pathways linking depression, adiposity and inflammatory markers in young adults. Brain Behav Immun 17:276–285CrossRefPubMed
31.
go back to reference Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M (2003) Inflamatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatr 54:566–572CrossRef Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M (2003) Inflamatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatr 54:566–572CrossRef
32.
go back to reference Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E (1999) Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrarions in post-traumatic stress disorder following accidental man-maid traumatic events. Biol Psychiatr 45:833–839CrossRef Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E (1999) Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrarions in post-traumatic stress disorder following accidental man-maid traumatic events. Biol Psychiatr 45:833–839CrossRef
33.
go back to reference Lustman J, Clouse RE, Williams MM (2006) Treating depression to prevent diabetes and its complications: understanding depression as a medical risk factor. Clin Diabetes 24:79–86CrossRef Lustman J, Clouse RE, Williams MM (2006) Treating depression to prevent diabetes and its complications: understanding depression as a medical risk factor. Clin Diabetes 24:79–86CrossRef
34.
go back to reference Chiba M, Hinokio Y, Suzuki S, Hirai M, Satoh Y, Tashiro A, Utsumi A, Awata T, Hongo M, Toyota T (2000) Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 49:1145–1149CrossRefPubMed Chiba M, Hinokio Y, Suzuki S, Hirai M, Satoh Y, Tashiro A, Utsumi A, Awata T, Hongo M, Toyota T (2000) Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 49:1145–1149CrossRefPubMed
Metadata
Title
Independent factors associated with depression in type 1 diabetes mellitus
Authors
Lucas Francisco Manarte
S. Dias
C. Góis
J. M. Boavida
Publication date
01-09-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0110-y

Other articles of this Issue 3/2010

Acta Diabetologica 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.